Health
High expression of VRK1 protein can reduce survival in neuroblastoma patients – News-Medical.Net
Researchers from the Departments of Cell Biology and Medical Physiology at the University of Seville have identified that a high expression of the human protein…
Researchers from the Departments of Cell Biology and Medical Physiology at the University of Seville have identified that a high expression of the human protein VRK1 is associated with tumour aggressiveness and low survival among neuroblastoma patients.
Aggressive neuroblastoma is one of the most common solid childhood cancers and causes disproportionately high mortality in affected children. Although advances have been made in recent years, the outlook for recovery in children affected by aggressive…
-
General21 hours agoFederal government funding extends cohealth GP services until July 2026
-
Business23 hours agoWhat I’d buy if I had to invest $20,000 in ASX 200 shares before the weekend
-
General6 hours agoMildura man given 28 years to pay $73,000 in unpaid fines and tolls
-
Noosa News23 hours agoAlleged violence within the CFMEU a ‘cancer’, administrator tells Queensland inquiry
